Clinical Trials in Denver

Showing 11641-11660 of 15,604 trials

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2

NCT00000327

The purpose of this study is to compare the clinical efficacy of daily vs. 3-day (MWF) buprenorphine/naloxone combination tablet administration and determine whether outcomes are improved when using a 3-day schedule in which all doses are ingested at the clinic vs. one in which take-home doses are given on intervening days.

Heroin DependenceOpioid-Related Disorders

University of Colorado, DenverStarted Jun 1997

Denver, Colorado, United States

WITHDRAWNPhase 2< 1 mile

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1

NCT00000326

The purpose of this study is to assess the clinical efficacy of the buprenorphine/naloxone combination tablet for alternate-day dosing and determine whether multiples of the daily dose are necessary to maintain an effective alternate day dosing regimen.

Heroin DependenceOpioid-Related Disorders

University of Colorado, DenverStarted Apr 1997

Denver, Colorado, United States

WITHDRAWNPhase 2< 1 mile

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5

NCT00000330

The purpose of this study is to assess the abuse liability and reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent volunteers

Heroin DependenceOpioid-Related Disorders

University of Colorado, DenverStarted Oct 1999

Denver, Colorado, United States

COMPLETEDPhase 2< 1 mile

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

NCT00530816

To evaluate the best overall response rate, safety and tolerability of carfilzomib in patients with relapsed or refractory multiple myeloma.

Multiple Myeloma

Amgen164 participantsStarted Sep 2007

Scottsdale, Arizona, United States • Beverly Hills, California, United States • Laguna Hills, California, United States +27 more locations

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Find Trials by Condition in Denver

The Diagnosis and Incidence of Critical Illness Polyneuromyopathy in Medical and Neurosurgical ICU Patients

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Inhibitor Development in Patients With Hemophilia A Undergoing Surgery

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

Vilazodone for the Treatment of Posttraumatic Stress Disorder

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

Pulsed Radiofrequency Energy to Treat Post-Bunionectomy Pain

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)